Efter en booster vaccination med tetanus toxoid (recall antigen) var evnen til at opbygge et immunrespons overfor tetanus toxoid bevaret hos patienterne i behandling med Raptiva.
Following booster vaccination with tetanus toxoid (recall antigen), the ability to mount an immune response to the tetanus toxoid was preserved in those patients undergoing Raptiva therapy.